MUMBAI, June 27, 2012 /PRNewswire/ --
The NextGen India 2012: Advances in Pharma and Biopharma Drug Delivery conference will be held on July 25-27 in Mumbai. This conference will focus on bringing practical case studies from concept to commercialisation stages including orals, injectables, liposomes, sustained release depots, nanotechnology and solubility enhancing techniques.
This 3-day event includes a 2-day conference taking place on July 26-27 and also features a focused workshop on hot melt extrusion, solid dispersion and solubility enhancing techniques on July 25.
The international and domestic expert speaker line-up for the conference include Dr Mahesh V Chaubal, Senior Director, Drug Development, Baxter Healthcare, USA; Dr Yatin Gokarn, Associate Director and Head - Pharmaceutical Process and Technology Development, Genentech, USA; Dr Jaymin C Shah, Research Fellow, Global Research and Development, Pfizer, USA; Dr Amarjit Singh, Head - Sandoz Development Center, Sandoz, India; Dr Harvinder Popli, Director, Corporate development, Ranbaxy Laboratories, India; Dr Sanju Dhawan, Head, COE - Formulation Technology, Dr Reddy's Laboratories, India; Dr Bhaswat S Chakraborty, Senior Vice President and Chair, R&D Core Committee, Cadila Pharmaceuticals, India among others and is sponsored by Dow Wolff Cellulosics as Gold Partner and Qualicaps as Silver Partner.
Visit www.nextgen-in.com for more information.
About UBM India:
UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details please visit the UBM India website, http://www.ubmindia.in.
Primary Media Contact: Asan Bano, email@example.com, 91-22-4046 1466
SOURCE UBM India Pvt. Ltd.